Trial
NCT00367718
Trial of VELCADE in Patients With Metastatic or Locally Recurrent Nasopharyngeal Carcinoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Johns Hopkins University
Collaborators
Janssen-Cilag Ltd.
Condition
Nasopharyngeal Carcinoma
Intervention
Velcade
Why stopped
PI left JHU and is not able to be reached for updates
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-05-18